Thus, SATB1 inhibition by miR-155 in malignant T cells promotes proliferation and induces the expression of the Th2 cytokines IL-5 and IL-9, which are involved in CTCL pathogenesis as growth factors and inflammatory mediators [59,60]. This evidence concerns the gene SATB1 and primary cutaneous T-cell non-Hodgkin lymphoma.